Ardelyx $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
麻豆入口 advised the sales agent in connection with the SEC-registered at-the-market offering by Ardelyx, Inc. of its common stock for up to an aggregate amount of $150 million. The common stock is listed on the Nasdaq Global Market under the symbol 鈥淎RDX.鈥
Based in Fremont, California, Ardelyx, Inc. is a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs.
The 麻豆入口 corporate team included partner Stephen Salmon and associates Paula Gergen and Sunny Xu. Associate Alison T. Chin provided intellectual property advice. Members of the 麻豆入口 team are based in the Northern California and New York offices.